Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells
Enrolling by invitation
Conditions studied: Coronary Artery Disease
In brief
This research is being done to understand how changes in DNA may put people at risk for developing coronary artery disease. Stem cells will be made using cells from blood and/or skin biopsy samples. We are trying to understand which specific changes in DNA negatively impact a person's health.
Key facts
- Study ID
- NCT01517425
- Run by
- Scripps Translational Science Institute
- People needed
- 200
- Starts
- 2012-11-01
- Expected to finish
- 2030-07-01
- Last updated by the study team
- 2025-01-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Cases:
- Previously enrolled in the CAD module of the Genebank at Scripps Clinic Registry
- Eligible to have their blood drawn
- Be reliable, cooperative and willing to comply with all protocol-specified procedures
- Able to understand and grant informed consent
- Controls:
- Previously enrolled in the Healthy Elderly Active Longevity (HEAL) Cohort
- Eligible to have their blood drawn
- Be reliable, cooperative and willing to comply with all protocol-specified procedures
- Able to understand and grant informed consent
You may not qualify if…
- Unwilling or unable to grant informed consent.
- Have a significant medical condition that in the Investigator's opinion may interfere with subject's study participation.
Where it is running
- Scripps Translational Science Institute — La Jolla, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.